Hinova Pharmaceuticals USA, Inc.
1 clinical trials · Sponsor
◉ Watch Hinova Pharmaceuticals USA, Inc.
| Record | Firm | Date |
|---|---|---|
| HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT03850795) | Hinova Pharmaceuticals USA, Inc. | 2021-03-15 |
Track Hinova Pharmaceuticals USA, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.